Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference219 articles.
1. Symon, Z. et al. Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes. Cancer 86, 72–78 (1999).
2. Perez, A. T., Domenech, G. H., Frankel, C. & Vogel, C. L. Pegylated liposomal doxorubicin (Doxil) for metastatic breast cancer: the Cancer Research Network, Inc., experience. Cancer Invest. 20 (Suppl. 2), 22–29 (2002).
3. O'Shaughnessy, J. A. Pegylated liposomal doxorubicin in the treatment of breast cancer. Clin. Breast Cancer 4, 318–328 (2003).
4. Schwonzen, M., Kurbacher, C. M. & Mallmann, P. Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer. Anticancer Drugs 11, 681–685 (2000).
5. Goncalves, A. et al. Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors. Anticancer Res. 23, 3543–3548 (2003).
Cited by
4297 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献